Ana Jimenez Peinado

Dr. Ana Jimenez Peinado

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in European Psychiatry
Verified
Journal Article
Open access
PDF file
APAna Jimenez Peinado
Ana Jimenez Peinado
DLDavid Laguna-Muñoz
David Laguna-Muñoz
MJMaría Jose Jaén-Moreno
María Jose Jaén-Moreno
CCCristina Camacho-Rodríguez
Cristina Camacho-Rodríguez
GPGloria Isabel del Pozo
Gloria Isabel del Pozo
FSFernando Sarramea
Fernando Sarramea
Background: Living with major depressive disorder (MDD) reduces life expectancy, with respiratory disease being a significant threat. However, evidence on respiratory disease in this population has not yet been meta-analyzed. Methods: This meta-analysis examines respiratory disease prevalence and odds ratio (OR) in patients with MDD and treatment resistant depression (TRD). A systematic literature search was conducted, with a snowball search of reference and citation lists. Inclusion criteria covered studies in MDD and TRD patients with confirmed diagnoses of respiratory diseases (asthma, chronic obstructive pulmonary disease [COPD], pneumonia, lung cancer, and tuberculosis), comparing with a control group when possible. Results: From 4,138 retrieved articles, 15 (including 476,927 individuals with MDD, 50,680 with TRD, and 1,108,979 control group) met the inclusion criteria. In MDD patients, COPD prevalence was 9.0% (95% CI: 3.8–19.6%), asthma 8.6% (95% CI: 5.7–12.8%), and pneumonia 2.5% (95% CI: 2.2–2.9%). In TRD patients, COPD prevalence was 9.9% (95% CI: 4.2–21.9%) and asthma 10.9% (95% CI: 10.7–11.2%), but meta-analysis limited to those diseases showed no significant relative risk differences. Compared to the general population, individuals with MDD had significantly higher rates of COPD (OR 1.79, 95% CI: 1.49–2.16), even higher in younger populations (1.85 [95% CI: 1.74–1.97]) and more prevalent in women. Conclusions: This first meta-analysis on this topic shows that MDD is associated with an increased risk of respiratory illness compared to the general population. The prevalence of asthma doubles the mean described in the general population worldwide, and in COPD, women and younger people are at particular risk. Prevention policies are urgently needed.

17 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
MJMaría Jose Jaén-Moreno
María Jose Jaén-Moreno
MAMatteo Aloi
Matteo Aloi
AAAna Alcántara-Montesinos
Ana Alcántara-Montesinos
APAna Jimenez Peinado
Ana Jimenez Peinado
CCCristina Camacho-Rodríguez
Cristina Camacho-Rodríguez
MMMaria José Moreno-Diaz
Maria José Moreno-Diaz
Background and Objective: Obesity is currently one of the major challenges in medicine. Research indicates that assessing eating habits can contribute significantly to the development of more effective treatment. This study aims to validate the Eating Behaviors Assessment for Obesity (EBA-O) in a sample of Spanish adults with overweight or obesity. Methods: This cross-sectional study included 384 participants. To evaluate the structure, reliability, and measurement invariance of the Spanish EBA-O, we conducted a confirmatory factor analysis (CFA), calculated McDonald’s omega for reliability, and carried out a hierarchical sequence of multigroup CFAs. Two-way MANOVA was used to assess the effects of sex and body mass index (BMI) categories on EBA-O scores. Results: CFA supported a second-order five-factor structure for the EBA-O, demonstrating excellent fit indices. It respected the configural, metric, and scalar invariance. The Spanish version of the EBA-O exhibited significant correlations with measures of binge eating, food addiction, and eating disorder psychopathology. Internal consistency was high (ω = 0.80). Significant effects of sex and BMI were observed across EBA-O subscales. Conclusions: The EBA-O appears to be a valid, reliable, and easy-to-use instrument for assessing eating behaviors among Spanish-speaking individuals with overweight or obesity. Its strong psychometric properties support its use in both clinical settings and research, enhancing the development of tailored interventions for this population.

3 December 2025 in European Psychiatry
Verified
Journal Article
Open access
PDF file
MJMaría Jose Jaén-Moreno
María Jose Jaén-Moreno
DLDavid Laguna-Muñoz
David Laguna-Muñoz
GPGloria Isabel del Pozo
Gloria Isabel del Pozo
CCCristina Camacho-Rodríguez
Cristina Camacho-Rodríguez
IGIpek Guler
Ipek Guler
FSFernando Sarramea
Fernando Sarramea
Background: The population with a serious mental illness (SMI) shows a high risk of premature mortality. Overexposed to multiple health risks throughout life, their main threat is physical illness, which starts earlier and is not diagnosed in time. Developing preventive actions is a public health priority. Methods: This longitudinal prospective study evaluated the predictive value of lung function on all-cause mortality in patients with schizophrenia (SCHIZ) or bipolar disorder. Patients aged 40–70 years, active smokers, and without preexisting respiratory disease underwent spirometry following American Thoracic Society/European Respiratory Society 2021 standards. Mortality data were collected through December 2022. Cox proportional hazards models and Kaplan–Meier survival curves analyzed the association between lung function, specifically forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and mortality, adjusting for relevant confounders (age, gender, abdominal circumference, and comorbidities). Results: Of 107 participants (mean age 49.3 years, 63.3% male) with SMI (72% SCHIZ) and active smokers, 8 (7.5%) died during the 6-year follow-up (5 cardiovascular and 3 cancer). Mean z -scores were −1.41 (SD = 1.22) for FEV1 and −0.99 (SD = 1.16) for FVC. Lower FEV1 and FVC z -scores were significantly associated with increased mortality risk ( p = 0.002 and p = 0.009, respectively). Kaplan–Meier analysis confirmed this association for FEV1 ( p = 0.039) and FVC ( p = 0.007) but not for gender, comorbidities (hypertension, diabetes, and dyslipidemia), or FEV1/FVC. A multivariate Cox regression model, adjusting for age and abdominal circumference, confirmed the independent predictive value of lower FEV1 z -score for mortality (hazard regression = 0.473, 95% confidence interval: 0.220–0.979, p = 0.044). Conclusions: Poorer lung function, especially lower FEV1, was independently associated with all-cause mortality in SMI. Spirometry, an easily implementable technique, could help to detect at-risk individuals and favor prevention initiatives.

2 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MJMaría Jose Jaén-Moreno
María Jose Jaén-Moreno
MAMatteo Aloi
Matteo Aloi
AAAna Alcantara-Montesinos
Ana Alcantara-Montesinos
APAna Jimenez Peinado
Ana Jimenez Peinado
CCCristina Camacho-Rodríguez
Cristina Camacho-Rodríguez
MMMaria José Moreno-Diaz
Maria José Moreno-Diaz
Background and objective: Obesity is currently one of the major challenges in medicine. Research indicates that evaluating eating habits can contribute significantly to the development of more effective treatments. This study aims to validate the Eating Behaviors Assessment for Obesity (EBA-O) in a sample of Spanish adults with overweight or obesity. Methods: This cross-sectional study involved 384 participants and employed confirmatory factor analysis (CFA) to examine the factorial structure of the EBA-O. Additionally, McDonald's ω coefficient and correlations with established measures of eating behaviors and psychopathology were run to measure internal consistency and convergent validity, respectively. Two-way MANOVA was used to assess the effects of sex and body mass index (BMI) categories on EBA-O scores. Results: CFA supported a second-order five-factor structure for the EBA-O, demonstrating excellent fit indices. The Spanish version of the EBA-O exhibited significant correlations with measures of binge eating, food addiction, and eating disorder psychopathology. Internal consistency was high (ω = 0.80). Significant effects of sex and BMI were observed across EBA-O subscales. Conclusions: The EBA-O appears to be a valid, reliable, and easy-to-use instrument for assessing eating behaviors among Spanish-speaking individuals with overweight or obesity. Its strong psychometric properties support its use in both clinical settings and research, enhancing the development of tailored interventions for this population.

28 April 2026 in European Eating Disorders Review
Verified
Journal Article
Open access
ECElvira Anna Carbone
Elvira Anna Carbone
CDCristiano Dani
Cristiano Dani
MGMatteo Geraci
Matteo Geraci
ARAlessia Romeo
Alessia Romeo
APAna Jimenez Peinado
Ana Jimenez Peinado
Cristina Segura GarciaCristina Segura Garcia
Cristina Segura Garcia
Objective: Previous research has shown that the COVID‐19 pandemic worsened eating‐disorder (ED) symptoms, but most studies have focused on inpatients and compared only two periods: pre‐COVID and the period following the pandemic's onset. Outpatient populations, particularly those with binge eating disorder (BED) and other specified feeding or eating disorders (OSFED), have been underrepresented. It remains unclear whether the pandemic influenced the clinical presentation at ED onset. This study aimed to examine differences in general and eating‐disorder–related psychopathology at first presentation among outpatients with all ED diagnoses before, during, and after the COVID‐19 lockdown in Italy. Methods: We retrospectively reviewed clinical records and assessment data from 400 patients seeking treatment for the first time at a specialised outpatient ED service. Patients were grouped into three periods: pre‐lockdown (01.01.2019–10.06.2020), lockdown (11.06.2020–30.09.2021), and post‐lockdown (01.10.2021–31.12.2022). These periods were defined to capture the effects of the lockdown while considering the DSM‐5 requirement that symptoms persist for at least 3 months to establish a diagnosis. Multivariate analyzes of variance were used to evaluate the effects of period, diagnosis, and their interaction on sociodemographic characteristics, eating‐disorder specific symptoms, and general psychopathology. Results: Significant differences were observed across diagnoses, including BED and OSFED. During the lockdown, patients exhibited greater concerns regarding dietary restriction, binge eating, and body, weight and shape across diagnostic groups compared with pre‐lockdown. The post‐lockdown period was associated with a younger age at ED onset and earlier initiation of dieting behaviours. Conclusions: By distinguishing pre‐lockdown, lockdown, and post‐lockdown phases and accounting for the DSM‐5 diagnostic timeline, this study extends prior research beyond the conventional pre/post pandemic comparison. The COVID‐19 lockdown was linked to more severe eating‐disorder specific and anxiety‐related symptoms at illness onset in outpatients across diagnoses, while the post‐lockdown period was marked by earlier onset and increased disorder‐specific concerns.